Trial Profile
Prospective study of ROMiplostim for rapid Platelet recovery after cord blood Transplantation, phase 1
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 30 Aug 2018
Price :
$35
*
At a glance
- Drugs Romiplostim (Primary)
- Indications Thrombocytopenia
- Focus Adverse reactions
- Acronyms PROMPT-1
- 30 Aug 2018 New trial record